Is It Time for Costco to Split?
Costco’s stock price has experienced enormous growth over the last…
Sell
46
DRMA Quote, Financials, Valuation and Earnings
Last price:
$1.34
Seasonality move
:
-39.31%
Day range:
$1.22 - $1.37
52-week range:
$1.00 - $13.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.58x
Volume:
127.3K
Avg. volume:
494.7K
1-year change:
-85.36%
Market cap:
$2.7M
Revenue:
--
EPS (TTM):
-$21.41
Earnings Data
Next earnings date for DRMA
--
Most recent earnings per share
-$2.04
Missed by $2.04
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.04 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$4.18 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$7.05 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$8.14 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$8.10 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$9.43 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$34.05 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$29.40 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$47.40 | -- | -- |
| 09/27/2022 | Q2 | -- | -- | -$58.50 | -- | -- |
| 05/31/2022 | Q1 | -- | -- | -$80.25 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$73.57 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$206.40 | -- | -- |
| 09/27/2021 | Q2 | -- | -- | -$42.53 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$66.42 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$11.42 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$17.22 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$23.68 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$40.95 | -- | -- |
Dermata Therapeutics Earnings Questions
-
How Much did Dermata Therapeutics Generate in Revenue Last Quarter?
Dermata Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Dermata Therapeutics Beat Earnings Last Quarter?
Dermata Therapeutics announced earnings per share of -$2.04 which represents a miss of analyst forecast a -- per share.
-
Is Dermata Therapeutics Profitable?
Dermata Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Dermata Therapeutics EPS Next Year?
Dermata Therapeutics's earnings are forecast to grow from -$40.05 per share to -- per share next year representing an increase of --.
-
When is Dermata Therapeutics's Earnings Date?
Currently, Dermata Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 2, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FedEx’s Spinoff Boost Its Stock Price?
In a pre-holiday surprise announcement, management at FedEx (NYSE:FDX) released…
Why Is Buffett Buying Verisign?
Warren Buffett has spent 2024 stockpiling cash, even going so…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Buy
100
IPX alert for Dec 31
IperionX [IPX] is down 9.31% over the past day.
Buy
58
QMCO alert for Dec 31
Quantum [QMCO] is down 13.43% over the past day.
Buy
55
SMLR alert for Dec 31
Semler Scientific [SMLR] is down 4.39% over the past day.
